The Fund aims to achieve above average capital growth.
Name | % Net Assets |
---|---|
Roche Holding AG | 5.6% |
BG GROUP | 4.6% |
EFG Eurobank Ergasias S.A. | 4.3% |
ASML Holding N.V. | 4.2% |
Lanxess AG | 3.8% |
Key | % Net Assets |
---|---|
Roche Holding AG | 5.6% |
BG GROUP | 4.6% |
EFG Eurobank Ergasias S.A. | 4.3% |
ASML Holding N.V. | 4.2% |
Other | 81.3% |
Date | 21-Nov-2024 |
---|---|
NAV | 6.41 |
Currency | EUR |
Change | 0.04 |
% | 0.65% |
YTD change | 0.67 |
YTD % | 11.66% |
Fund Inception | 12/07/2004 |
---|---|
Fund Manager | Phil Cliff |
TER | - |
Minimum Investment | |
---|---|
Initial | 75000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research